Gene info: ID 4781

Gene: NFIB

GENE ID: 4781

Description: nuclear factor I B

Gene type: protein-coding

Location: 9p23-p22.3

dbXrefs: Ensembl:ENSG00000147862 MIM:600728 Vega:OTTHUMG00000021027 UniprotKB:O00712

RefSeq: NC_000009.12

Retrived from: SNP Mapped

SNPs: 1 ANCO-SNPs

Phenotype: AD

# Publications: 0

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 6.135e-1 (AD) 6.425e-1 (ND)

ANCO-SNPs

SNP ID	Position	Alleles	Trait	Variation Type
rs2382468	chr9:14303062 (GRCh38.p7)	T>G	alcohol dependence	SNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
GATM	0.805
ARHGAP5	0.795
EIF4EBP2	0.789
NEBL	0.788
NADK2	0.782
PSAT1	0.781
GLUD1	0.78
GOLIM4	0.78
PTN	0.776
ADD3	0.776

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
OR4F5	-0.613
OR4F29	-0.573
NRG1	-0.271
RHO	-0.267
NPBWR2	-0.265
LIPH	-0.264
HRG	-0.256
PKLR	-0.255
INSM2	-0.247
ARID3C	-0.247

There is no DrugBank record for this gene !

ID	Drug Name	Action	PubMed
C006718	1,12-benzoperylene	"1,12-benzoperylene results in increased expression of NFIB mRNA"	26377693
C049325	1,2-dithiol-3-thione	"1,2-dithiol-3-thione results in decreased expression of NFIB mRNA"	19162173
C029790	2,2',3',4,4',5-hexachlorobiphenyl	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
C029790	2,2',3',4,4',5-hexachlorobiphenyl	"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NFIB mRNA"	23829299
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NFIB mRNA"	21394737
C081766	2,4,4'-trichlorobiphenyl	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
C014024	2,4,5,2',4',5'-hexachlorobiphenyl	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
C009828	2,4,5,2',5'-pentachlorobiphenyl	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene affects the expression of NFIB mRNA"	21346803
C009407	2,5,2',5'-tetrachlorobiphenyl	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
C009407	2,5,2',5'-tetrachlorobiphenyl	"2,5,2',5'-tetrachlorobiphenyl results in increased expression of NFIB mRNA"	23829299
C026114	2-xylene	2-xylene results in increased expression of NFIB mRNA	20359517
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C035207	4-amino-2,6-dinitrotoluene	"4-amino-2,6-dinitrotoluene affects the expression of NFIB mRNA"	21346803
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
D000082	Acetaminophen	Acetaminophen results in decreased expression of NFIB mRNA	21420995\|2669055
D000082	Acetaminophen	Acetaminophen affects the expression of NFIB mRNA	17562736
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of NFIB mRNA	16483693
D018501	Antirheumatic Agents	Antirheumatic Agents results in increased expression of NFIB mRNA	24449571
D001205	Ascorbic Acid	Ascorbic Acid results in increased expression of NFIB mRNA	15305145
D001554	Benzene	Benzene results in increased expression of NFIB mRNA	20359517
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of NFIB mRNA	19770486\|2156981
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NFIB mRNA"	19150397\|2001819
D004958	Estradiol	Estradiol affects the expression of NFIB mRNA	14699072
D004958	Estradiol	[Estradiol co-treated with Progesterone] results in increased expression of NFIB mRNA	20660070
D004958	Estradiol	Estradiol results in decreased expression of NFIB mRNA	19167446
D004958	Estradiol	[Progesterone co-treated with Estradiol] results in increased expression of NFIB mRNA	17404688
C006780	bisphenol A	bisphenol A results in decreased expression of NFIB mRNA	25912373
C006780	bisphenol A	bisphenol A results in increased expression of NFIB mRNA	26063408
C006780	bisphenol A	bisphenol A affects the expression of NFIB mRNA	25181051
C013418	bromfenacoum	bromfenacoum results in decreased expression of NFIB protein	28903499
C018475	butyraldehyde	butyraldehyde results in decreased expression of NFIB mRNA	26079696
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of NFIB mRNA	18560533
D002251	Carbon Tetrachloride	Carbon Tetrachloride affects the expression of NFIB mRNA	17484886
D002330	Carmustine	NFIB mRNA affects the susceptibility to Carmustine	16365179
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in decreased expression of NFIB mRNA	23650126
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in decreased expression of NFIB mRNA	18178546
D004390	Chlorpyrifos	Chlorpyrifos results in decreased expression of NFIB mRNA	18668222
C018021	cobaltous chloride	cobaltous chloride results in decreased expression of NFIB mRNA	19320972
D019327	Copper Sulfate	Copper Sulfate results in increased expression of NFIB mRNA	19549813
D003471	Cuprizone	Cuprizone results in decreased expression of NFIB mRNA	26577399
D016572	Cyclosporine	Cyclosporine results in decreased expression of NFIB mRNA	20106945\|2798913
D016572	Cyclosporine	Cyclosporine results in decreased expression of NFIB mRNA	19770486
C093628	cyproconazole	cyproconazole results in decreased expression of NFIB mRNA	22334560
D003561	Cytarabine	Cytarabine results in increased expression of NFIB mRNA	21198554
D002945	Cisplatin	[Cisplatin co-treated with jinfukang] results in decreased expression of NFIB mRNA	27392435
D002945	Cisplatin	Cisplatin results in decreased expression of NFIB mRNA	19561079\|2739243
D004052	Diethylnitrosamine	Diethylnitrosamine results in decreased expression of NFIB mRNA	19638242
D015127	9,10-Dimethyl-1,2-benzanthracene	"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFIB mRNA"	22485181
D004237	Diuron	Diuron results in decreased expression of NFIB mRNA	21551480\|2515243
D004317	Doxorubicin	Doxorubicin results in decreased expression of NFIB mRNA	17888722
C118739	entinostat	entinostat results in increased expression of NFIB mRNA	26272509
C118739	entinostat	"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C109476	epoxiconazole	epoxiconazole results in decreased expression of NFIB mRNA	22334560
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of NFIB mRNA	12655037
C004912	ethylbenzene	ethylbenzene results in increased expression of NFIB mRNA	20359517
D005020	Ethyl Methanesulfonate	Ethyl Methanesulfonate results in decreased expression of NFIB mRNA	23649840
D005472	Fluorouracil	Fluorouracil results in decreased expression of NFIB mRNA	16557594
D005485	Flutamide	Flutamide results in decreased expression of NFIB mRNA	24136188
D005557	Formaldehyde	Formaldehyde results in decreased expression of NFIB mRNA	23649840
D019833	Genistein	Genistein results in increased methylation of NFIB gene	28505145
D005897	Glafenine	Glafenine results in decreased expression of NFIB mRNA	24136188
D017313	Fenretinide	Fenretinide results in decreased expression of NFIB mRNA	28973697
D015759	Ionomycin	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NFIB mRNA	25613284
C544151	jinfukang	[Cisplatin co-treated with jinfukang] results in decreased expression of NFIB mRNA	27392435
C544151	jinfukang	jinfukang results in decreased expression of NFIB mRNA	27392435
C045463	leflunomide	leflunomide results in increased expression of NFIB mRNA	28988120
D001556	Lindane	Lindane results in decreased expression of NFIB mRNA	17785943
C482199	lipopolysaccharide, E coli O55-B5	"[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFIB mRNA"	20371263
D008344	Maneb	[Paraquat co-treated with Maneb] affects the expression of NFIB mRNA	22563483
D008345	Manganese	Manganese results in increased expression of NFIB mRNA	17175027
C025340	manganese chloride	manganese chloride results in increased expression of NFIB mRNA	17175027
C042720	mercuric bromide	mercuric bromide results in increased expression of NFIB mRNA	26272509
C042720	mercuric bromide	"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
D008701	Methapyrilene	Methapyrilene results in decreased expression of NFIB mRNA	16393664
D008713	Methimazole	Methimazole results in decreased expression of NFIB mRNA	17403546
D008752	Methylene Chloride	Methylene Chloride results in increased expression of NFIB mRNA	20359517
D008777	Methyltestosterone	Methyltestosterone results in decreased expression of NFIB mRNA	29191790
D009151	Mustard Gas	Mustard Gas affects the expression of NFIB mRNA	15651846
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of NFIB mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in decreased expression of NFIB mRNA"	25554681
C051752	nefazodone	nefazodone results in decreased expression of NFIB mRNA	24136188
D009532	Nickel	Nickel results in decreased expression of NFIB mRNA	25583101
C029938	nickel sulfate	nickel sulfate results in decreased expression of NFIB mRNA	22714537
C012655	nimesulide	nimesulide results in decreased expression of NFIB mRNA	24136188
C507134	ON 01910	ON 01910 results in increased expression of NFIB mRNA	22351695
C030110	oxaliplatin	NFIB protein results in decreased susceptibility to oxaliplatin	21087353
C030110	oxaliplatin	[oxaliplatin co-treated with Topotecan] results in increased expression of NFIB mRNA	25729387
C496932	panobinostat	"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
C496932	panobinostat	panobinostat results in increased expression of NFIB mRNA	26272509
D010269	Paraquat	[Paraquat co-treated with Maneb] affects the expression of NFIB mRNA	22563483
D010269	Paraquat	Paraquat results in increased expression of NFIB mRNA	22563483
C410127	PCB 180	"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA"	25510870
D010426	Pentosan Sulfuric Polyester	Pentosan Sulfuric Polyester results in decreased expression of NFIB mRNA	28973697
C494474	perchlorate	perchlorate results in decreased expression of NFIB mRNA	17403546
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid affects the expression of NFIB mRNA	19429403
C023036	perfluorooctanoic acid	perfluorooctanoic acid affects the expression of NFIB mRNA	19429403
D010634	Phenobarbital	Phenobarbital results in decreased expression of NFIB mRNA	23091169
D010634	Phenobarbital	Phenobarbital results in decreased expression of NFIB mRNA	19162173
D010662	Phenylmercuric Acetate	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA"	27188386
D010662	Phenylmercuric Acetate	Phenylmercuric Acetate results in increased expression of NFIB mRNA	26272509
C006253	pirinixic acid	pirinixic acid results in decreased expression of NFIB mRNA	16221962\|1844570
C027373	potassium chromate(VI)	potassium chromate(VI) results in decreased expression of NFIB mRNA	22714537
D011374	Progesterone	[Estradiol co-treated with Progesterone] results in increased expression of NFIB mRNA	20660070
D011374	Progesterone	[Progesterone co-treated with Estradiol] results in increased expression of NFIB mRNA	17404688
D011374	Progesterone	Progesterone results in increased expression of NFIB mRNA	17404688
C045950	propiconazole	propiconazole results in decreased expression of NFIB mRNA	21278054\|2233456
D011441	Propylthiouracil	Propylthiouracil results in decreased expression of NFIB mRNA	17403546
C043680	ptaquiloside	ptaquiloside results in decreased expression of NFIB mRNA	23274088
C014175	pyrazolo(3,4-d)pyrimidine	"pyrazolo(3,4-d)pyrimidine analog affects the expression of NFIB mRNA"	21152443
C428725	pyridaben	pyridaben results in increased expression of NFIB mRNA	22563483
D012715	Sesame Oil	Sesame Oil results in increased expression of NFIB mRNA	29191790
C009277	sodium arsenate	sodium arsenate results in decreased expression of NFIB mRNA	21795629
C009277	sodium arsenate	sodium arsenate results in increased expression of NFIB mRNA	21795629
D013467	Sulindac	"[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFIB mRNA"	20371263
C047246	temozolomide	NFIB mRNA affects the susceptibility to temozolomide	16365179
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of NFIB mRNA	21570461\|2405805
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of NFIB mRNA	16922920
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of NFIB mRNA	20959002\|2121527
D013755	Tetradecanoylphorbol Acetate	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA	16979875
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NFIB mRNA	25613284
C009495	titanium dioxide	titanium dioxide results in decreased expression of NFIB mRNA	23557971
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of NFIB mRNA	28065790
D014050	Toluene	Toluene results in increased expression of NFIB mRNA	20359517
D019772	Topotecan	[oxaliplatin co-treated with Topotecan] results in increased expression of NFIB mRNA	25729387
D014212	Tretinoin	Tretinoin results in increased expression of NFIB mRNA	21934132
C011559	tributyltin	tributyltin results in increased expression of NFIB mRNA	29191790
D014241	Trichloroethylene	Trichloroethylene results in increased expression of NFIB mRNA	20359517
D014241	Trichloroethylene	Trichloroethylene results in increased expression of NFIB mRNA	15363585\|1944899
D014241	Trichloroethylene	Trichloroethylene results in increased expression of NFIB mRNA	19448997
C015559	trimellitic anhydride	trimellitic anhydride results in decreased expression of NFIB mRNA	19042947
C013320	tris(2-butoxyethyl) phosphate	tris(2-butoxyethyl) phosphate affects the expression of NFIB mRNA	29024780
C057693	troglitazone	troglitazone results in decreased expression of NFIB mRNA	28973697
D014635	Valproic Acid	Valproic Acid results in decreased expression of NFIB mRNA	23179753\|2493525
D014635	Valproic Acid	Valproic Acid results in increased expression of NFIB mRNA	23179753\|2718838
D001335	Vehicle Emissions	Vehicle Emissions affects the methylation of NFIB gene	25560391
C025643	vinclozolin	vinclozolin affects the expression of NFIB mRNA	19015723
D015032	Zinc	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA	16979875

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000978	RNA polymerase II proximal promoter sequence-specific DNA binding	-	IDA	19540848
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	IBA	21873635
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	IDA	9099724 19540848
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	ISA	-
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	ISM	19274049
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	NAS	19274049
GO:0001077	transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding	-	IDA	19540848
GO:0003677	DNA binding	-	IDA	9099724 19540848

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000122	negative regulation of transcription by RNA polymerase II	-	IBA	21873635
GO:0002062	chondrocyte differentiation	-	ISS	-
GO:0006260	DNA replication	-	IEA	-
GO:0006366	transcription by RNA polymerase II	-	IEA	-
GO:0010001	glial cell differentiation	-	ISS	-
GO:0021740	principal sensory nucleus of trigeminal nerve development	-	ISS	-
GO:0021960	anterior commissure morphogenesis	-	ISS	-
GO:0030902	hindbrain development	-	IEA	-
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IBA	21873635
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IDA	9099724 19540848
GO:0060486	Clara cell differentiation	-	ISS	-
GO:0060509	type I pneumocyte differentiation	-	ISS	-
GO:0060510	type II pneumocyte differentiation	-	ISS	-
GO:0060662	salivary gland cavitation	-	IEA	-
GO:0060689	cell differentiation involved in salivary gland development	-	IEA	-
GO:0061141	lung ciliated cell differentiation	-	ISS	-
GO:0071679	commissural neuron axon guidance	-	ISS	-
GO:1902894	negative regulation of pri-miRNA transcription by RNA polymerase II	-	IMP	18384814
GO:2000791	negative regulation of mesenchymal cell proliferation involved in lung development	-	ISS	-
GO:2000795	negative regulation of epithelial cell proliferation involved in lung morphogenesis	-	ISS	-

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0001650	fibrillar center	-	IDA	-
GO:0005634	nucleus	-	IBA	21873635
GO:0005634	nucleus	-	IDA	9099724
GO:0044300	cerebellar mossy fiber	-	ISS	-

KEGG ID	KEGG Term

Reactome ID	Reactome Term	Evidence
R-HSA-73980	RNA Polymerase III Transcription Termination	IEA
R-HSA-74158	RNA Polymerase III Transcription	IEA
R-HSA-74160	Gene expression (Transcription)	IEA
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	IEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal